In an intriguing murine model of CAV, CCR5-deficient and CD8-deficient mice, transiently treated with anti-CD4 therapy, developed an exaggerated antibody response after cardiac transplantation, leading to the generation of DSAs and subsequent vasculopathy (56). This evidence concerns the gene CD8A and vascular disorder.